Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

BackgroundPirfenidone is an antifibrotic compound able to slow down disease progression in patients with idiopathic pulmonary fibrosis (IPF).ObjectiveTo investigate the safety and efficacy of pirfenidone in patients with IPF in a real-life setting.MethodsThis was a multicenter, retrospective, real-l...

Full description

Bibliographic Details
Main Authors: Argyrios Tzouvelekis, Theodoros Karampitsakos, Paschalis Ntolios, Vasilios Tzilas, Evangelos Bouros, Evangelos Markozannes, Ioanna Malliou, Aris Anagnostopoulos, Andreas Granitsas, Paschalis Steiropoulos, Katerina Dimakou, Serafeim Chrysikos, Nikolaos Koulouris, Demosthenes Bouros
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Medicine
Subjects:
pirfenidone
safety
efficacy
idiopathic pulmonary fibrosis
treatment
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2017.00213/full

Internet

http://journal.frontiersin.org/article/10.3389/fmed.2017.00213/full

Similar Items